Rockland, Massachusetts, December 6, 2007 - EMD Serono, Inc. announced today the availability of easypod®, the first of its kind automated device in the growth hormone therapeutic area. easypod® was ...
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that about 30,000 patients [1] have been treated using Merck Serono's growth hormone injection device, easypod™ since its ...
GENEVA, February 14, 2011 /PRNewswire/ -- Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the enrollment of the first patients in ECOS, the Easypod Connect ...
Delivering daily injections of growth hormones has become easier for parents now that EMD Serono has launched a new electronic device called the “easypod.” The Rockland biotech company created the ...
In 2003 Merck Serono, a world leader in the field of biotechnology engaged PDD to design an auto-injector for its Growth Hormone (GH) therapy product Saizen®. In what was a saturated and static market ...
The growth hormone therapy market had become crowded and static. With little variety in the efficacy of drugs or treatments on offer, Merck Serono wanted to develop a device that would achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results